fr

CARMAT receives FDA conditional approval to initiate the second cohort of the EFS study in the United States

2011 half-year results in line with expectations

Download

Great success of the rights issue

Download

Launch of a €25.5m rights issue with preferential subscription rights

Download

CARMAT and BULL announce the development of portable equipment for recipients of CARMAT's artificial heart

Download

CARMAT files a clinical trial application with the French health authorities for its artificial heart

Download

Presentation of study results on anatomic compatibility

Download

Annual results in line with expectations

Download

CARMAT_appoints Valerie Leroy as Director of Marketing and IR

Download
Top of page